22 results
S-4
SYRS
Syros Pharmaceuticals Inc.
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
.
Syros is subject to U.S. and foreign anti-corruption and anti-money laundering laws with respect to its operations andnon-compliance
with such laws can … and national anti-bribery and anti-money laundering laws in countries in which Syros conducts activities. Anti-corruption laws are interpreted broadly
8-K
EX-1.1
dmrcz mqr
20 Jan 21
Syros Announces Proposed Offering of Common Stock
4:04pm
8-K
EX-1.1
bcfhynekokxy0i nbc9
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
424B3
vhkf c4d7wa51w
8 Aug 22
Prospectus supplement
5:47pm
8-K
EX-1.1
kvps 4wrypi0
8 Apr 19
Entry into a Material Definitive Agreement
12:00am
10-K
a0ltz
20 Mar 17
Annual report
12:00am
8-K
EX-1.2
8h5is
8 Apr 19
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
243 qlu0mivwb
7 Dec 20
Entry into a Material Definitive Agreement
6:05am